Enhabit (NYSE:EHAB) Issues Quarterly Earnings Results

Enhabit (NYSE:EHAB) announced its quarterly earnings data on Wednesday. The company reported $0.14 EPS for the quarter, hitting analysts’ consensus estimates of $0.14, FiscalAI reports. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The company had revenue of $270.40 million during the quarter, compared to the consensus estimate of $270.56 million.

Enhabit Price Performance

Shares of NYSE EHAB traded down $0.01 during mid-day trading on Thursday, hitting $13.60. 272,745 shares of the stock were exchanged, compared to its average volume of 1,275,489. The company has a market cap of $688.30 million, a P/E ratio of -54.40 and a beta of 1.56. The stock’s fifty day simple moving average is $10.96 and its two-hundred day simple moving average is $9.30. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58. Enhabit has a twelve month low of $6.47 and a twelve month high of $13.64.

Wall Street Analyst Weigh In

A number of research analysts recently commented on EHAB shares. Truist Financial set a $13.80 target price on Enhabit in a research note on Monday, February 23rd. Jefferies Financial Group lowered shares of Enhabit from a “buy” rating to a “hold” rating and boosted their price target for the company from $12.50 to $13.80 in a report on Monday, February 23rd. UBS Group reaffirmed a “neutral” rating and set a $13.80 price objective (up from $12.00) on shares of Enhabit in a report on Tuesday, February 24th. Citigroup reissued a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Three analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $13.31.

Institutional Investors Weigh In On Enhabit

Hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Enhabit by 8.2% in the 3rd quarter. Vanguard Group Inc. now owns 3,393,069 shares of the company’s stock valued at $27,178,000 after purchasing an additional 256,559 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Enhabit by 1.0% in the fourth quarter. Geode Capital Management LLC now owns 1,187,434 shares of the company’s stock valued at $10,951,000 after buying an additional 11,583 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Enhabit by 30.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 866,539 shares of the company’s stock valued at $7,989,000 after buying an additional 201,269 shares during the last quarter. Marshall Wace LLP lifted its position in Enhabit by 59.2% during the 3rd quarter. Marshall Wace LLP now owns 792,981 shares of the company’s stock worth $6,352,000 after buying an additional 294,999 shares in the last quarter. Finally, Bank of America Corp DE grew its holdings in Enhabit by 73.3% during the 3rd quarter. Bank of America Corp DE now owns 687,934 shares of the company’s stock worth $5,510,000 after acquiring an additional 290,978 shares during the last quarter.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.